Although not identical to human insulin, animal based insulins were a highly effective treatment. The development of insulin therapy transformed diabetes from an acute, fatal disease to a chronic ...

InsuJet™ Needle-free Device utilizes advanced jet injection technology that delivers precise doses of ... leading to missed doses and suboptimal diabetes management. The InsuJet™ offers an alternative ...

According to this report, the global insulin market is estimated to be valued at US$ 87 billion in the year 2028, growing at a CAGR of 8.8% in the period 2021 to 2028. Growth of the market is driven ...

for the delivery of U-100 insulin to individuals with diabetes and subcutaneous biosimilar products using NuGen's InsuJetTM device and consumables. U-100 insulin is the standard and most used ...